Methods for identifying the effect of a drug agent on the...

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving glucose or galactose

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C424S009100, C424S009200

Reexamination Certificate

active

07910323

ABSTRACT:
Provided herein are methods for determining the metabolism of one or more sugars and/or fatty acids, and applications thereof. Such applications include determining the rate of glycogen synthesis and glycolysis, which are believed to be early markers for predicting elevated risk of diabetes and cardiovascular disease. Other applications include methods for screening drugs that effect sugar and/or fatty acid metabolism. The methods are useful for at least partially characterizing drugs for desirable or undesirable (toxic) characteristics. Drugs that are at least partially characterized using the methods of the invention can then be further developed in pre-clinical testing and clinical trials. Such drugs may be found to be useful in treating obesity, diabetes, cardiovascular disease, and other disorders of metabolism.

REFERENCES:
patent: 4065552 (1977-12-01), Costa
patent: 4332784 (1982-06-01), Smith et al.
patent: 4889126 (1989-12-01), Doddrell et al.
patent: 4940658 (1990-07-01), Allen et al.
patent: 5026909 (1991-06-01), Zolotarev et al.
patent: 5042488 (1991-08-01), Ackerman
patent: 5167948 (1992-12-01), Wenzel et al.
patent: 5209919 (1993-05-01), Turteltaub et al.
patent: 5317098 (1994-05-01), Shizuya et al.
patent: 5338686 (1994-08-01), Hellerstein
patent: 5354662 (1994-10-01), Stone et al.
patent: 5376355 (1994-12-01), Turteltaub et al.
patent: 5394236 (1995-02-01), Murnick
patent: 5439803 (1995-08-01), Ross et al.
patent: 5506147 (1996-04-01), Kolhouse et al.
patent: 5597548 (1997-01-01), Sherry et al.
patent: 5665377 (1997-09-01), Gonella et al.
patent: 5665562 (1997-09-01), Cook
patent: 5783445 (1998-07-01), Murnick
patent: 5855921 (1999-01-01), Somlyai et al.
patent: 5910403 (1999-06-01), Hellerstein
patent: 5916537 (1999-06-01), Kajiwara et al.
patent: 5922554 (1999-07-01), Fielding et al.
patent: 5924995 (1999-07-01), Klein et al.
patent: 5961470 (1999-10-01), Wagner et al.
patent: 6010846 (2000-01-01), Hellerstein
patent: 6031228 (2000-02-01), Abramson
patent: 6071245 (2000-06-01), Kohno et al.
patent: 6117656 (2000-09-01), Seed
patent: 6284219 (2001-09-01), Ajami et al.
patent: 6329208 (2001-12-01), Jones et al.
patent: 6355416 (2002-03-01), Abramson
patent: 6461806 (2002-10-01), Hellerstein
patent: 6461870 (2002-10-01), Yatscoff et al.
patent: 6468802 (2002-10-01), Yatscoff et al.
patent: 6599750 (2003-07-01), Yatscoff et al.
patent: 6602715 (2003-08-01), Yatscoff et al.
patent: 6610270 (2003-08-01), Ajami
patent: 6625547 (2003-09-01), Korzekwa et al.
patent: 6642059 (2003-11-01), Chait et al.
patent: 6653076 (2003-11-01), Franza, Jr. et al.
patent: 6653090 (2003-11-01), Lopaschuk
patent: 6680203 (2004-01-01), Dasseux et al.
patent: 6764817 (2004-07-01), Schneider
patent: 6783751 (2004-08-01), Heumann
patent: 6808875 (2004-10-01), Hellerstein
patent: 6835927 (2004-12-01), Becker et al.
patent: 6849396 (2005-02-01), Schneider
patent: 6872575 (2005-03-01), Regnier
patent: 6887712 (2005-05-01), Medford et al.
patent: 6902719 (2005-06-01), Wagner
patent: 6906320 (2005-06-01), Sachs et al.
patent: 7001587 (2006-02-01), Hellerstein
patent: 7022834 (2006-04-01), Hellerstein
patent: 7048907 (2006-05-01), Groman et al.
patent: 7057168 (2006-06-01), Miller et al.
patent: 7084396 (2006-08-01), Schneider
patent: 7255850 (2007-08-01), Hellerstein
patent: 7256047 (2007-08-01), Malloy et al.
patent: 7262020 (2007-08-01), Hellerstein
patent: 7307059 (2007-12-01), Hellerstein
patent: 7357913 (2008-04-01), Hellerstein
patent: 7410633 (2008-08-01), Hellerstein
patent: 7449171 (2008-11-01), Hellerstein
patent: 7504233 (2009-03-01), Hellerstein
patent: 2003/0068634 (2003-04-01), Hellerstein
patent: 2003/0119069 (2003-06-01), Schneider et al.
patent: 2003/0133871 (2003-07-01), Hellerstein
patent: 2003/0148533 (2003-08-01), Malloy et al.
patent: 2003/0180710 (2003-09-01), Lee et al.
patent: 2003/0180800 (2003-09-01), Lee et al.
patent: 2003/0211036 (2003-11-01), Degani et al.
patent: 2003/0224420 (2003-12-01), Hellerstein et al.
patent: 2003/0228259 (2003-12-01), Hellerstein
patent: 2004/0081994 (2004-04-01), Hellerstein
patent: 2004/0115131 (2004-06-01), Hellerstein
patent: 2004/0121305 (2004-06-01), Wiegand et al.
patent: 2004/0152994 (2004-08-01), Meier-Augenstein
patent: 2004/0191916 (2004-09-01), Gross et al.
patent: 2004/0253647 (2004-12-01), Mathews et al.
patent: 2005/0003375 (2005-01-01), Franza et al.
patent: 2005/0014181 (2005-01-01), Galis et al.
patent: 2005/0092910 (2005-05-01), Geromanos et al.
patent: 2005/0118724 (2005-06-01), Bateman et al.
patent: 2005/0153346 (2005-07-01), Schneider
patent: 2005/0175982 (2005-08-01), Iwatani et al.
patent: 2005/0201937 (2005-09-01), Hellerstein
patent: 2005/0202406 (2005-09-01), Hellerstein
patent: 2005/0221278 (2005-10-01), Iwatani et al.
patent: 2005/0238577 (2005-10-01), Hellerstein
patent: 2005/0238581 (2005-10-01), Kurland et al.
patent: 2005/0255509 (2005-11-01), Hellerstein et al.
patent: 2005/0281745 (2005-12-01), Lee et al.
patent: 2006/0008796 (2006-01-01), Hellerstein
patent: 2006/0020440 (2006-01-01), Hellerstein
patent: 2006/0094057 (2006-05-01), Hellerstein
patent: 2006/0100903 (2006-05-01), Lee et al.
patent: 2006/0105322 (2006-05-01), Iwatani et al.
patent: 2006/0105339 (2006-05-01), Hellerstein
patent: 2006/0120961 (2006-06-01), Schneider et al.
patent: 2006/0251576 (2006-11-01), Hellerstein
patent: 2006/0280682 (2006-12-01), Hellerstein
patent: 2007/0248540 (2007-10-01), Hellerstein
patent: 2008/0003179 (2008-01-01), Hellerstein
patent: 2009/0041661 (2009-02-01), Hellerstein
patent: 0826377 (1998-03-01), None
patent: 2001-211782 (2001-08-01), None
patent: 968036 (1982-10-01), None
patent: WO-90/11371 (1990-10-01), None
patent: WO-93/20800 (1993-10-01), None
patent: WO-93/25705 (1993-12-01), None
patent: WO-95/13096 (1995-05-01), None
patent: WO-98/51820 (1998-11-01), None
patent: 00/12535 (2000-03-01), None
patent: WO-00/13025 (2000-03-01), None
patent: WO-00/63683 (2000-10-01), None
patent: WO-01/80715 (2001-11-01), None
patent: WO-01/84143 (2001-11-01), None
patent: WO-03/061479 (2003-07-01), None
patent: WO-03/068919 (2003-08-01), None
patent: WO-03/087314 (2003-10-01), None
patent: WO-2004/003493 (2004-01-01), None
patent: WO-2004/011426 (2004-02-01), None
patent: WO-2004/021863 (2004-03-01), None
patent: WO-2004/024941 (2004-03-01), None
patent: WO-2004/025270 (2004-03-01), None
patent: WO-2004/042360 (2004-05-01), None
patent: WO-2005/009597 (2005-02-01), None
patent: WO-2005/015155 (2005-02-01), None
patent: WO-2005/033652 (2005-04-01), None
patent: WO-2006/050130 (2006-05-01), None
patent: WO-2006/081521 (2006-08-01), None
patent: WO-2006/107814 (2006-10-01), None
“NCBI Blast: Protein Sequence (17 letters),” located at <http://blast.ncbi.nlm.nih.gov/Blast.cgi> visited on May 29, 2008, 5 pages.
“New Diagnostic Technique Could Help Treat AIDS,”Agence France-Presse, Dow Jones News/Retrieval, Feb. 17, 1998, pp. 1-2.
Ackermans, M. T. et al. (2001). “The Quantification of Gluconeogenesis in Healthy Men by 2H2O and [2-13C]Glycerol Yields Different Results: Rates of Gluconeogenesis in Healthy Men Measured with 2H2O are Higher than those Measured with [2-13C]Glycerol,”The Journal of Clinical Endocrinology&Metabolism86(5):2220-2226.
Adami, H. O. et al. (1995). “The Aetiology and Pathogenesis of Human Breast Cancer,”Mutation Research333:29-35.
Airhart, J. et al. (1974). “Compartmentation of Free Amino Acids for Protein Synthesis in Rat Liver,”The Biochemical Journal140:539-545.
Ajie, H. O. et al. (1995). “In Vivo Study of the Biosynthesis of Long-Chain Fatty Acids Using Deuterated Water,”The American Journal of Physiology269:E247-E252.
Anderson, R.W. et al. (1998). “Direct HIV Cytopathicity Cannot Account for CD4 Decline in AIDS in the Presence of Homeostasis: A Worst-Case Dynamic Analysis,”Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology17:245-252.
Antelo, Fernando et al. (2002) “Adipose Triglyceride (TG) Turnover and De Novo Lipogenesis (DNL) in Humans: Measurement by Long-

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Methods for identifying the effect of a drug agent on the... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for identifying the effect of a drug agent on the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for identifying the effect of a drug agent on the... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2720852

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.